2. Dopamine Transporter
Background Structure DAT Localization
Dopamine synthesis
Dopamine Signaling
Alternate DAT substrates
Na+ dependence of DAT
Cl- dependence of DAT
Cloning of DAT gene
DAT knockout mouse
Site-directed mutagenesis
LeuTAa crystal structure
Lipid Rafts and DAT
Cholesterol Role
Cholesterol Effect on Drugs
3. •Amino acid transporter
•High homology to other neurotransmitter transporters
Serotonin Transporter
Glutamate Transporter
Dopamine Transporter
12. DAT: Transports other substrates
Cocaine Amphetamine MPP
AWESOME AWESOME NOT AWESOME
13. Amphetamines reduce surface DAT and
increase dopamine release
Signal
Elevates dopamine signaling
Blocks
VMAT
Reverse
Transport of
Dopamine
through DAT
14. Amphetamines requires DAT for dopamine release
(Jones 1998)
Amphetamine treated
Wildtype DAT
Knockout DAT-/-
Dopamine release due to
amphetamine treatment is
DAT dependent
16. Amphetamines reduce DAT surface expression
(Saunders 2000)
Flourescently labeled DAT localizes to the cell membrane
When treated with amphetamines
Becomes internalized
20. MPTP leads to selective dopaminergic cell death
Signal
Converted to MPP+ via MAO-B
Interferes with complex I
Cell death
Loss of dopaminergic signaling
21. MPTP Requires DAT for Toxicity
• Markers of DA neurons
• Lost due to MPP exposure
• Protected in DAT-/-
(Gainetdenov 2002)
22. DAT: Transports other substrates
Cocaine MPP
AWESOME AWESOME NOT AWESOME
Resulting in permanent damage
Sometimes when
making this
You can actually get
that
Amphetamine
38. Finding DAT Gene: cDNA library screen
If expressed clone is dopamine transporter
Radiolabeled dopamine will enter oocyte
Oocytes washed and homogenized
Radioactivity measured
39. DAT cDNA behaves like DAT
Cocaine blocks uptake
Uptake is Na+ dependent
RNA results in DA uptake
40. Finding DAT Gene: cDNA library screen
•Go back to bacterial plates
•PCR insert
•Sequence insert
ampR
DAT cDNA
47. DAT -/- resistant to
cocaine and amphetamine
Homozygouse does not increase movement
Heterozygous reduced increase in movement
48. Crystal Structure of LeuTAa
• Bacterial orthologue of DAT
• Aquifex aeolicus
• Crystalized in complex with
Leucine
Two sodium ions
49. • PCR cloned genomic LeuTAa
• Overexpressed protein in bacteria IPTG inducible
• His-tag translational fusion with thrombin site
T7 LeuTAa His
Thrombin Site
Crystal Structure of LeuTAa
50. • C41 cells
express toxic proteins
• Include seleno-methionine in media
• Label protein with seleno-methionine
heavy atom helps solve phase problem
Crystal Structure of LeuTAa
51. • Isolated cell membranes
• Solubilized in 40mM dodecylmaltoside
• Passed over ion affinity chromatography column
• Remove His-tag via thrombin digestion
• Size exclusion column with 40mM o-noctyl-B-
glucopyranoside (B-OG)
• Dialyzed O/N with low salt and same B-OG
Crystal Structure of LeuTAa
52. Crystal Structure of LeuTAa
Hang Drop Vapour Diffusion
SealedCrystals Remain
•Concentratedprotein on slide
•Flip upside down
•Sealed container
•Above reservoir
•As it dries
•Leaves precipitate to form crysta
53. Crystal Structure of LeuTAa
X-ray Diffraction
•PEG 550 cryoprotection
•Liquid nitrogen flash freeze
•Pass X-ray laser through cyrsta
•Can rotate
•Collect refraction data
54. Crystal Structure of LeuTAa
Multiwavelength Anomalous Dispersion
•Intensity of spot is measured
•Gives wavelength amplitude
•Not phase
•Both are needed
•Solution:MAD
55. Crystal Structure of LeuTAa
Multiwavelength Anomalous Dispersion
•Heavy atoms such as
Selenium
•Electrons absorb certain wavelengths
•Re-emit after a delay
•Causes a phase shift
•Can back calculate to get initial phase
60. Identifying Amino Acids necessary for DA Transport
Site-directed mutagenesis
Mutate specific AA
Test DA uptake in cell culture
Asp 79 Misense Mutants
WT
Suggests Asp79 binds dopamine
Asp79 mutants significantly lower DA uptake
62. Identifying Cl- interacting amino acids
Neurotransmitter symporters
all Cl- dependent
Bacteria orthologues
Cl- independent
Identify amino acids that are
shared in neurotransmitter transporters
different in bacterial transporters
Site directed mutagenesis
Screen for Cl- independence
68. Measuring Lateral Mobility
FRAP
• Fluorescence recovery after photobleaching
• Fluorescently tagged membrane protein
• Photobleach a small area
• Causes loss of flourescence
69. Measuring Lateral Mobility
FRAP
• Fluorescence recovery after photobleaching
• Fluorescently tagged membrane protein
• Photobleach a small area
• Causes loss of flourescence
• If the protein can move freely
Flourescence recovers
70. Measuring Lateral Mobility
FRAP
• Fluorescence recovery after photobleaching
• Fluorescently tagged membrane protein
• Photobleach a small area
• Causes loss of flourescence
• If the protein movement is restricted
Photobleaching remains
71. DAT does not recover photobleach when
in neuronal cells
Suggests immobile in this cell type
(Adkins 2007)
72. Immobility of DAT is cholesterol
dependent
• mBCD: causes cholesterol depletion
• Cytochalasin D interferes with actin
DAT anchored by cholesterol and cytoskeleton
73. DAT in both membrane and non-
membrane rafts
Present in both raft and non-raft fractions
• Na/K ATPase
Non-raft marker
• GM1
Raft marker
80. Treatment with wsCholesterol decreases DA
uptake
Increased wsCholesterol
leads to decreased DA uptake
Conflicts with previous report
No change due to MGCD
82. Critiques: How do we know cholesterol
getting into membrane
• Adding water soluble cholesterol
Cholesterol
MBCD
• Used only HEK cell line
• Did not then check membrane fractions for
higher cholesterol content
• Other paper suggests depletion
…..but they didn’t check either
Interpretation may be backward